Cost of management of nonvalvular atrial fibrillation in Brazzaville (Congo): preliminary findings

Mbolla, Bertrand Fikahem Ellenga; Matingou, A.R.; Ikama, Méo Stéphane; Mongo-Ngamami, Solange Flore; Landa, Christian Michel Kouala; Gombet, Thierry Raoul; Kimbally-Kaky, Suzy-Gisèle

doi:10.1684/mst.2014.0432

Cited by 1 publication

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2%) and about half of them were prospective (Table S1). The remaining articles (n = 10) presented information on the trends in mortality attributed to AF using modeling analysis, and on the cost of AF treatment, anticoagulation utilization, and monitoring …”

Section: Resultsmentioning

confidence: 99%

“…This cost did not include the management of comorbidities or complications. Whereas the mean monthly salary of patients was 174 (SD: 170) USD; 98% of patients did not have health insurance and were, therefore, paying out‐of‐pocket …”

Section: Resultsmentioning

confidence: 99%

“…From 292 records identified from database searches and additional reference lists screening, 72 articles were included in this review (Figure S1). Most of the articles (n = 55) reported primary data on the prevalence, risk factors, and treatment of AF .…”

Section: Resultsmentioning

confidence: 99%

“…There is limited information on the cost of AF management in SSA. Nevertheless, available data suggest that this cost is high, especially for the vast majority of people who have low incomes and have to pay for their health expenditures out‐of‐pocket, in the absence of universal health coverage in most SSA countries …”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

A review of the epidemiology of atrial fibrillation in sub‐Saharan Africa

Noubiap

Nyaga²

2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

This systematic review summarizes the data on the prevalence, risk factors, complications, and management of atrial fibrillation (AF) in sub‐Saharan Africa (SSA). Bibliographic databases were searched from inception to 31 May 2019, to identify all published studies providing data on AF in populations living in SSA. A total of 72 studies were included. The community‐based prevalence of AF was 4.3% and 0.7% in individuals aged ≥40 years and aged ≥70 years, respectively. The prevalence of AF ranged between 6.7% and 34.8% in patients with ischemic stroke, between 9.5% and 46.8% in those with rheumatic heart disease (RHD), between 5% and 31.5% in patients with dilated cardiomyopathy. The main risk factors for AF were hypertension, affecting at least one‐third of patients with AF, and valvular heart disease (12.3%‐44.4%) and cardiomyopathy (~20%). Complications of AF included heart failure in about two thirds and stroke in 10% to 15% of cases. The use of anticoagulation for stroke prevention was suboptimal. Rate control was the most frequent therapeutic strategy, used in approximately 65% to 95% of AF patients, with approximately 80% of them achieving rate control. The management of AF was associated with exorbitant cost. In conclusion, AF seems to have a higher prevalence in the general population than previously thought and is mostly associated with hypertension, cardiomyopathy, and RHD in SSA. It is associated with a high incidence of heart failure and stroke. The management of AF is suboptimal in SSA, especially with a low uptake of oral anticoagulation.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations